CLSX vs VXUS
Tradr 2X Long CLSK Daily ETF vs Vanguard Total International Stock ETF
Which is better, CLSX or VXUS?
Trading-Leveraged Equity against Large Cap Blend.
VXUS has a lower expense ratio. VXUS led over 1Y and the full window.
MarketXLS is not an investment adviser. This comparison is generated automatically from market data and is for information only. A Best mark means the better reading on that one measure, not a recommendation to buy.
Side-by-Side Comparison
| Metric | CLSX | VXUS |
|---|---|---|
| Expense Ratio | 1.46% | 0.05%Best |
| AUM | $14M | $158.1B |
| Dividend Yield | 0.00% | 2.51% |
| Holdings | 6 | 8,747 |
| YTD Return | -29.34% | +13.44%Best |
| 1Y Return | -65.27% | +21.98%Best |
| 3Y Return (annualized) | - | +20.89% |
| 5Y Return (annualized) | - | +9.16% |
| Volatility (annualized) | 194.4% | 14.1%Best |
| Max Drawdown | -93.2% | -11.3%Best |
| $10,000 over 1 years | $5,042 | $12,001Best |
| Fund Family | Tradr ETFs | Vanguard (US) |
| Category | Alternative | Equity |
| Style | Trading-Leveraged Equity | Large Cap Blend |
| Inception | Sep 15, 2025 | Jan 26, 2011 |
Not shown on this pair: Top 10 Weight.
Volatility and max drawdown, and the $10,000 over 1 years row, are measured over the window both funds cover: Sep 16, 2025 to Sep 25, 2026 (1 years).
CLSX vs VXUS growth
Month-end closes. Both lines start at 0% in the first month shown, so the gap between them is the difference in growth across that window. The full view covers the 1 years both funds cover.
CLSX vs VXUS Performance
Tradr 2X Long CLSK Daily ETF (CLSX) is an ETF from Tradr ETFs and Vanguard Total International Stock ETF (VXUS) is an ETF from Vanguard (US). Over the past year CLSX returned -65.27% while VXUS returned +21.98%. Year to date, CLSX is down 29.34% versus a gain of 13.44% for VXUS.
Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
CLSX has been the more volatile fund, with annualized monthly volatility of 194.4% compared with 14.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -93.2% for CLSX and -11.3% for VXUS. Drawdown depth is what each fund did in the worst stretch of the window measured above.
The two funds' monthly returns correlate at 0.43. They move together some of the time, and apart the rest.
Fees and Cost Over Time
CLSX charges 1.46% per year while VXUS charges 0.05%. On a $10,000 position that is $146 vs $5 annually, a gap of $141 per year that compounds over a long holding period. On income, CLSX currently yields 0.00% against 2.51% for VXUS.
You are not choosing between two funds in isolation.
Whichever of CLSX and VXUS you pick has to sit alongside everything else you own. Add the rest and see what the combination actually holds.
Free for up to 10 holdings. No account needed.
Frequently Asked Questions
Which is cheaper, CLSX or VXUS?
CLSX has an expense ratio of 1.46% while VXUS charges 0.05%. VXUS is the cheaper option, by $141 a year on a $10,000 investment.
Which performed better, CLSX or VXUS?
Over the past year CLSX returned -65.27% vs +21.98% for VXUS, so VXUS leads on 1-year performance. Over the longest common window we track (1 years), CLSX annualized -49.58% vs +20.01% for VXUS. Past performance does not guarantee future results. This is information, not a recommendation.
Which is riskier, CLSX or VXUS?
CLSX has been the more volatile fund at 194.4% annualized versus 14.1% for VXUS. Worst drawdown: CLSX -93.2% vs VXUS -11.3%.
Should I hold both CLSX and VXUS?
CLSX and VXUS have a monthly-return correlation of 0.43, so their returns are far enough apart for the mix to behave differently from either one alone. This is information, not a recommendation.
Which pays a higher dividend, CLSX or VXUS?
CLSX yields 0.00% while VXUS yields 2.51%, so VXUS currently pays the higher dividend yield.
Is VXUS better than CLSX?
VXUS has a lower expense ratio. VXUS led over 1Y and the full window. Which one suits a particular account depends on what it is for. This is information, not a recommendation.